Medplus Health Services Ltd

Q1 FY26

Medplus Health Services Ltd Q1 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q1 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹690

Market cap₹8.3K Cr

P/E39.4

Updated23 Aug 2026

Read4 min read

The short version

Growth is expected to pick up from mid to high single digit to potentially double-digit in the next couple of years, driven by store expansion and branded products sales. Management expects topline growth to improve with a focus on both branded and private label products, realigning employee incentives accordingly.

From Medplus Health Services Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Growth is expected to pick up from mid to high single digit to potentially double-digit in the next couple of years, driven by store expansion and branded products sales.
Private label share is planned to grow steadily by around 0.5% per quarter, supporting margin expansion.
Management expects topline growth of about 1% on MRP sales or 0.5% on net sales quarterly once supply chain and incentive realignments stabilize.
Addition of 600 new stores planned this year, with approximately 100 being franchised, aiding growth.
Supply chain improvements will increase fill rates and sales.
Renewed employee incentives targeting both private label and branded sales will help accelerate volume growth.

2 more points management made on revenue & sales performance

Profitability & Margins

Management expects topline growth to improve with a focus on both branded and private label products, realigning employee incentives accordingly.
Targeting 600 new store additions in FY'26, including at least 100 franchise stores, supporting growth.
EBITDA margin expected to grow modestly, around 5%, possibly approaching 6% eventually, but very high optimism (beyond 6%) is cautioned against.
Gross margin may improve by approximately 0.2% for every 0.5% increase in private label sales; private label share expected to grow about 0.5% every quarter.
Growth in pharmacy GMB was about 6.8% YoY in the quarter; management anticipates a gradual return to double-digit growth with balanced margins over the next 1-2 years.
EBITDA margin could be impacted temporarily by the number of new stores opened, but is not expected to be significant due to controlled expansion.

2 more points management made on profitability & margins

See what Medplus Health Services Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex per new store is typically around Rs. 7 to 8 lakh, including rental advance, totaling about Rs. 10 to 11 lakh per store (Page 10).
The company plans to add around 600 new stores in the current fiscal year, up from 350 stores added last year (Page 11).
Expansion in the diagnostics business is currently on hold until membership reaches closer to 200,000-250,000 (Page 7).
No immediate large-scale expansion of warehouses mentioned; currently, there are about 40 warehouses servicing 300-450 stores each, with sufficient capacity to support growth (Page 9).

2 more points management made on capital expenditure plans

Fundraising & Capital Structure

The transcript does not explicitly mention any current or future plans for fundraising through debt or equity. Key points related to financial strategy include: - Focus on operational improvements, such as supply chain optimization and employee incentives, to drive growth and margins. - Expansion plan of adding around 600 stores in the current year, with partial franchisee model adoption.

2 more points management made on fundraising & capital structure

See what Medplus Health Services Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided transcript from MedPlus Health Services Limited's Q1 FY'26 earnings call does not contain any information regarding their current or expected order book or pending orders. The discussion mainly covers topics such as store additions, private label sales growth, supply chain improvements, inventory management, diagnostics business metrics, and margins. Therefore, there is no disclosed data on order book or pending orders in the available document.

Medplus Health Services Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹1.9K Cr, net profit ₹64 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Medplus Health Services Ltd's management said in earlier quarters

Others in Retailing this season

Shankara Building (Q1 FY26)
Strong volume growth in steel business with a 35% year-on-year increase in Q1, indicating good demand. Key concall takeaways from Shankara Building Products…
Aditya Bir. Fas. (Q1 FY26)
Ethnic businesses posted a 25% revenue growth and sharp EBITDA margin expansion by 1600 bps with strong wedding season demand, signaling sustained…
Crizac (Q1 FY26)
Management foresees sustaining margins around 25% and cost of services around 70% of revenue. Key concall takeaways from Crizac Ltd's Q1 FY26 earnings call…
Aditya Birla Lifestyle Brands Ltd (Q1 FY26)
Working capital cycle stable between 13%-15% of sales, ensuring steady cash flow. Key concall takeaways from Aditya Birla Lifestyle Brands Ltd's Q1 FY26…

Compare:vs Eternal Ltd vs Avenue Super.vs Trent Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Medplus Health Services Ltd Q1 FY26 results?

What is Medplus Health Services Ltd share price analysis?

Medplus Health Services Ltd currently shows a neutral. The stock trades at a P/E of 39.4 with a market cap of ₹8,293 Cr. Investors should review the full earnings analysis for detailed insights.

Is Medplus Health Services Ltd planning capital expenditure?

Capex per new store is typically around Rs.

Keep Medplus Health Services Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.